Catalyst Pharmaceuticals (CPRX) Gross Margin (2019 - 2026)
Catalyst Pharmaceuticals posted quarterly Gross Margin of 90.31% for Q1 2026, up 298.0% year-on-year from 22.69% in Q1 2025, and up 8.92% on a QoQ basis from 82.91% in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 8 years of Gross Margin data on file, last reported at 90.31% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 298.0% year-over-year to 90.31%; the trailing twelve-month figure through Mar 2026 stood at 85.96% (down 16.0% YoY), and the FY2025 full-year result was 85.19%, down 81.0% from the prior year.
- Gross Margin for Q1 2026 stood at 90.31%, up from 82.91% in the prior quarter.
- Across five years, Gross Margin topped out at 90.31% in Q1 2026 and bottomed at 81.57% in Q4 2022.
- The 5-year median for Gross Margin is 85.94% (2025), against an average of 85.91%.
- The widest annual swing landed in 2022, when Gross Margin plunged 211 bps; it then jumped 413 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 81.57% in 2022, then climbed by 5 bps to 85.7% in 2023, then decreased by 1 bps to 84.74% in 2024, then fell by 2 bps to 82.91% in 2025, then advanced by 9 bps to 90.31% in 2026.
- The last three Gross Margin figures came in at 90.31% (Q1 2026), 82.91% (Q4 2025), and 84.73% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 90.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.31% |
| Dec 31, 2025 | 82.91% |
| Sep 30, 2025 | 84.73% |
| Jun 30, 2025 | 85.94% |
| Mar 31, 2025 | 87.33% |
| Dec 31, 2024 | 84.74% |
| Sep 30, 2024 | 85.02% |
| Jun 30, 2024 | 87.45% |
| Mar 31, 2024 | 87.29% |
| Dec 31, 2023 | 85.70% |
| Sep 30, 2023 | 86.20% |
| Jun 30, 2023 | 87.90% |
| Mar 31, 2023 | 88.35% |
| Dec 31, 2022 | 81.57% |
| Sep 30, 2022 | 83.12% |
| Jun 30, 2022 | 85.61% |
| Mar 31, 2022 | 86.33% |
| Dec 31, 2021 | 80.82% |
| Sep 30, 2021 | 85.23% |
| Jun 30, 2021 | 87.50% |
| Mar 31, 2021 | 84.50% |
| Dec 31, 2020 | 84.30% |
| Sep 30, 2020 | 86.77% |
| Jun 30, 2020 | 86.02% |
| Mar 31, 2020 | 85.75% |
| Dec 31, 2019 | 85.40% |
| Sep 30, 2019 | 85.80% |
| Jun 30, 2019 | 85.22% |
| Mar 31, 2019 | 86.25% |